# High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)

> **NCT07166731** · — · RECRUITING · sponsor: **Acandis GmbH** · enrollment: 536 (estimated)

## Conditions studied

- Carotid Artery Disease
- Symptomatic Carotid Artery Stenosis
- Carotid Artery Stenting
- Carotid Plaque Imaging
- Embolic Stroke of Undetermined Source
- Carotid Artery Thrombosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07166731
- **Lead sponsor:** Acandis GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2032-05-31
- **Final completion:** 2032-06
- **Target enrollment:** 536 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07166731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07166731, "High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07166731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*